What are the side effects of immunotherapy and when are they dangerous

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Immunotherapy Side Effects: What You Should Know

Immunotherapy works by activating your immune system to fight cancer, which is powerful—but it also means your immune system can sometimes attack healthy cells. This causes side effects called immune-related adverse events (irAEs).

Common Side Effects

Mild to Moderate (Most Frequent):

  • Fatigue and weakness
  • Skin rashes or itching
  • Diarrhea or constipation
  • Nausea
  • Loss of appetite
  • Headaches
  • Joint or muscle pain
  • Fever

More Serious (Less Common but Important):

  • Pneumonitis (lung inflammation)
  • Colitis (severe inflammation of the colon)
  • Hepatitis (liver inflammation)
  • Thyroid problems
  • Kidney inflammation
  • Heart inflammation (myocarditis)
  • Neurological effects (nerve damage, confusion)
  • Severe skin reactions

When Are They Dangerous?

Side effects become medically urgent when they:

  • Persist or worsen despite initial management
  • Affect vital organs (lungs, heart, liver, kidneys)
  • Cause severe symptoms: uncontrollable diarrhea, difficulty breathing, chest pain, severe headache
  • Develop suddenly or progress rapidly
  • Occur in combination (multiple organ systems affected)
  • Don't respond to standard treatments like steroids

According to ASCO (American Society of Clinical Oncology) Guidelines, severe immune-related adverse events occur in 10-15% of patients receiving single-agent immunotherapy, and rates increase with combination treatments.

Critical Timeline

Report immediately to your care team if you experience:

  • Difficulty breathing or chest pain
  • Severe abdominal pain with diarrhea
  • Confusion or severe headache
  • Yellowing of skin/eyes (liver problems)
  • Severe rash spreading rapidly
  • Palpitations or fainting

These warrant urgent evaluation—don't wait for a scheduled appointment.

Management Approach

The NCCN Guidelines recommend:

  • Grade 1-2 (mild): Usually managed with supportive care, monitoring
  • Grade 3-4 (severe): Often requires stopping immunotherapy temporarily or permanently, plus corticosteroids or other immunosuppressive medications
  • Organ-specific toxicity: May need specialist consultation (pulmonologist, gastroenterologist, cardiologist, etc.)

Key Questions for Your Oncology Team

  1. Which side effects are most common with MY specific immunotherapy drug?
  2. What symptoms should I report immediately vs. manage at home?
  3. How will you monitor me for serious side effects? (blood work, imaging, etc.)
  4. What's your plan if I develop a severe immune-related adverse event?
  5. Are there preventive medications I should take? (Some patients receive steroids or other preventive treatments)

Important Context

Most immunotherapy side effects are manageable when caught early and treated appropriately. The key is communication—report new or worsening symptoms promptly rather than waiting. Your oncology team has experience managing these effects and can adjust your treatment plan as needed.

The goal is balancing cancer control with quality of life, and that requires your active partnership in reporting how you're feeling.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2